68 related articles for article (PubMed ID: 2296325)
1. [Treatment of AIDS patients with zidovudine].
Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH
Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325
[TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas].
Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J
Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038
[TBL] [Abstract][Full Text] [Related]
3. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset.
Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA
Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group.
Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655
[TBL] [Abstract][Full Text] [Related]
5. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study].
Perenboom R; Reiss P; Danner SA; van 't Wout JW
Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287
[TBL] [Abstract][Full Text] [Related]
6. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
[TBL] [Abstract][Full Text] [Related]
7. Zidovudine and the natural history of the acquired immunodeficiency syndrome.
Moore RD; Hidalgo J; Sugland BW; Chaisson RE
N Engl J Med; 1991 May; 324(20):1412-6. PubMed ID: 2020297
[TBL] [Abstract][Full Text] [Related]
8. [Survival of patients with zidovudine resistant HIV].
Gøtzsche PC; Nielsen C; Gerstoft J; Nielsen CM; Vestergaard BF
Ugeskr Laeger; 1994 Jan; 156(2):185-6. PubMed ID: 7905217
[TBL] [Abstract][Full Text] [Related]
9. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group.
Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA
AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341
[TBL] [Abstract][Full Text] [Related]
10. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection.
Cox PH; Martin MA; Styer CM; Beall GN
Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666
[TBL] [Abstract][Full Text] [Related]
11. [Zidovudine treatment and need of blood transfusion in patients with AIDS].
Ligtenberg PC; Hoepelman IM; Vrehen HM; Borleffs JC
Ned Tijdschr Geneeskd; 1991 Jan; 135(4):130-3. PubMed ID: 2002856
[TBL] [Abstract][Full Text] [Related]
12. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study.
Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B
Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group.
Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE
Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950
[TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
15. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study.
Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J
Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263
[TBL] [Abstract][Full Text] [Related]
16. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee.
Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M
Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442
[TBL] [Abstract][Full Text] [Related]
17. Modelling progression of CD4-lymphocyte count and its relationship to survival time.
De Gruttola V; Tu XM
Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983
[TBL] [Abstract][Full Text] [Related]
18. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment].
Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA
Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746
[TBL] [Abstract][Full Text] [Related]
19. [Myopathy and zidovudine].
Mateo O; Gato A; Ballesteros P; Benito L; Pontes MJ; Esquinas G
Enferm Infecc Microbiol Clin; 1992 Oct; 10(8):474-6. PubMed ID: 1489776
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
Swanson CE; Tindall B; Cooper DA
AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]